General MedicationsINTRAVENOUSStandard
SODIUM BICARBONATE
SODIUM BICARBONATE
Standard Dose
50MEQ/50ML (1MEQ/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview SODIUM BICARBONATE is listed in Drugs@FDA under application 219701 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM BICARBONATE Form and strength SOLUTION;INTRAVENOUS - 50MEQ/50ML (1MEQ/ML) Sponsor ANTHEA PHARMA Submission history Latest submission status date: 2025-06-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview SODIUM BICARBONATE is listed in Drugs@FDA under application 219701 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM BICARBONATE Form and strength SOLUTION;INTRAVENOUS - 50MEQ/50ML (1MEQ/ML) Sponsor ANTHEA PHARMA Submission history Latest submission status date: 2025-06-26 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.